Search

Your search keyword '"Walker, David A."' showing total 41 results
Start Over Author "Walker, David A." Journal rheumatology
41 results on '"Walker, David A."'

6. Viewpoint: Nurses educating patients about drugs.

Author

Robinson, Sandra, Adebajo, Ade, and Walker, David

Subjects
NURSING education, PATIENT education, HEALTH literacy, RHEUMATOID arthritis, DECISION making, ANTIRHEUMATIC agents, MEDICAL referrals, PATIENTS' attitudes
Abstract

Educating patients about the drugs they take is essential for them to take them safely and effectively. This education is now commonly given by nurses as part of the huge expansion in the nurse specialist role. However, training for this role has not kept pace with practice. Nurses have expressed variable confidence in this role and expressed a wish for more formal training. Current practice often puts the information rather than the patient at the centre of the consultation with the nurse dominating the conversation. Cues to address the patient agenda are commonly missed. An animated patient who interrupts is probably not having their educational needs met. Education of the professionals around how to perform this task in an optimal way is necessary and should result in better efficacy and safety of the drugs. This could be achieved by incorporating features of Shared Decision Making and the Calgary–Cambridge consultation techniques into training and the consultation. Personalization by attention to patient preferences, language and health literacy is essential. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

9. P128 A subgroup analysis of the efficacy of filgotinib for patients with moderately active RA following an inadequate response to methotrexate

Author

Buch, Maya H, primary, Walker, David, additional, Kiely, Patrick D W, additional, Edwards, Christopher J, additional, Barry, Jane, additional, McCaughey, Gerard, additional, Akroyd, Laura, additional, Tiamiyu, Iyabode, additional, Ye, Lei, additional, Chen, Kun, additional, and Taylor, Peter C, additional

Published
2021
Full Text
View/download PDF

11. P133 Filgotinib in patients with RA with inadequate response to methotrexate: FINCH 1 52-week efficacy and patient reported outcomes data

Author

Walker, David, primary, Kivitz, Alan, additional, Tanaka, Yoshiya, additional, Lee, Susan, additional, Ye, Lei, additional, Hu, Hao, additional, Matzkies, Franziska, additional, Bartok, Beatrix, additional, Guo, Ying, additional, Sundy, John S, additional, Jahreis, Angelika, additional, Besuyen, Robin, additional, Combe, Bernard, additional, van der Heijde, Désirée, additional, Simon-Campos, J-Abraham, additional, Baraf, Herbert S B, additional, Kumar, Uma, additional, Tasset, Chantal, additional, Mozaffarian, Neelufar, additional, Landewé, Robert B M, additional, Bae, Sang-Cheol, additional, Keystone, Edward, additional, and Nash, Peter, additional

Published
2021
Full Text
View/download PDF

16. O09 Pooled safety analyses from Phase 3 studies of filgotinib in patients with RA

Author

Walker, David, primary, Winthrop, Kevin, primary, Genovese, Mark C, primary, Combe, Bernard G, primary, Tanaka, Yoshiya, primary, Kivitiz, Alan, primary, Matzkies, Franziska, primary, Bartok, Beatrix, primary, Ye, Lie, primary, Guo, Ying, primary, Tasset, Chantal, primary, Sundy, John S, primary, Keystone, Edward, primary, Westhovens, Rene, primary, Rigby, William, primary, and Burmester, Gerd R, primary

Published
2020
Full Text
View/download PDF

17. P216 Effects of filgotinib on anaemia, thrombocytopoenia and leukopoenia: results from a Phase 3 study in patients with active RA and prior inadequate response or intolerance to bDMARDs

Author

Walker, David, primary, Genovese, Mark C, primary, Kalunian, Kenneth, primary, Gottenberg, Jacques-Eric, primary, Bartok, Beatrix, primary, Tan, YingMeei, primary, Guo, Ying, primary, Tasset, Chantal, primary, Sundy, John S, primary, de Vlam, Kurt, primary, and Takeuchi, Tsutomu, primary

Published
2020
Full Text
View/download PDF

19. P210 Efficacy and safety of filgotinib for patients with RA with inadequate response to methotrexate: FINCH1 primary outcome results

Author

Walker, David, primary, Combe, Bernard G, primary, Kivitiz, Alan J, primary, Tanaka, Yoshiya, primary, van der Heijde, Désirée, primary, Matzkies, Franziska, primary, Bartok, Beatrix, primary, Ye, Lie, primary, Guo, Ying, primary, Tasset, Chantal, primary, Sundy, John S, primary, Mozaffarian, Neelufar, primary, Landewé, Robert B. M, primary, Bae, Sang-Cheol, primary, Keystone, Edward C, primary, and Nash, Peter, primary

Published
2020
Full Text
View/download PDF

20. 086 Safety and efficacy of filgotinib in a phase 3 trial of patients with active rheumatoid arthritis and inadequate response or intolerance to biologic disease modifying anti-rheumatic drugs

Author

Walker, David, primary, Genovese, Mark C, additional, Kalunian, Kenneth, additional, Gottenberg, Jacques-Eric, additional, de Vlam, Kurt, additional, Mozaffarian, Neelufar, additional, Bartok, Beatrix, additional, Matzkies, Franziska, additional, Gao, Jie, additional, Guo, Ying, additional, Tasset, Chantal, additional, Sundy, John S, additional, and Takeuchi, Tsutomu, additional

Published
2019
Full Text
View/download PDF

23. Optimizing treatment with tumour necrosis factor inhibitors in rheumatoid arthritis—a proof of principle and exploratory trial: is dose tapering practical in good responders?

Author

Ibrahim, Fowzia, primary, Lorente-Cánovas, Beatriz, additional, Doré, Caroline J, additional, Bosworth, Ailsa, additional, Ma, Margaret H, additional, Galloway, James B, additional, Cope, Andrew P, additional, Pande, Ira, additional, Walker, David, additional, and Scott, David L, additional

Published
2017
Full Text
View/download PDF

26. 216. BARICITINIB, METHOTREXATE, OR BARICITINIB PLUS METHOTREXATE IN PATIENTS WITH MODERATELY-TO-SEVERELY ACTIVE RHEUMATOID ARTHRITIS WHO HAD RECEIVED LIMITED OR NO TREATMENT WITH DMARDS: EFFICACY AND SAFETY RESULTS FROM THE 52-WEEK PHASE 3 RA-BEGIN STUDY

Author

Durez, Patrick, primary, Walker, David, additional, Geusens, Piet, additional, Van den Bosch, Filip, additional, Shaikh, Saeed, additional, Roccatello, Dario, additional, Tahir, Hasan, additional, Zamani, Omid, additional, Stoykov, Ivaylo, additional, Otawa, Susan, additional, Rogai, Veronica, additional, Larsson, Esbjörn, additional, Holzkämper, Thorsten, additional, Arthanari, Subhashini, additional, Pum, Georg, additional, Liu Leage, Soyi, additional, Gjertsson, Inger, additional, Puttini, Piercarlo Sarzi, additional, Kekow, Jörn, additional, and De La Torre, Inmaculada, additional

Published
2017
Full Text
View/download PDF

29. 45 years in rheumatology.

Author

Walker, David

Subjects
*SERIAL publications, *MEDICAL protocols, *COMMUNICATION, *PHYSICIAN-patient relations, *RHEUMATOLOGY, *ACCESS to information
Abstract

The author reflects on his experience of working in rheumatology for 45 years. He recalls walking into the Rheumatology unit at the Royal Victoria Infirmary in Newcastle, New South Wales for his first Senior House Officer job on a medical rotation in August 1978. He mentions the change in their practice beyond recognition. He also comments on the change of the people around them, with the establishment of a whole multidisciplinary team.

Published
2024
Full Text
View/download PDF

39. Ethnic minority musculoskeletal health: Improving health literacy.

Author

Adebajo, Ade, Shikoh, Shahzad, Kumar, Kanta, and Walker, David

Subjects
RHEUMATOID arthritis treatment, COMMUNICATION, DRUGS, ETHNIC groups, HEALTH attitudes, HEALTH education, HEALTH promotion, INDIGENOUS peoples, MEDICAL personnel, PATIENT-professional relations, MINORITIES, MUSCULOSKELETAL system diseases, PATIENT compliance, HEALTH self-care, SELF-efficacy, SERIAL publications, VITAMIN D, WHITE people, CULTURAL competence, HEALTH literacy, KNEE pain, HEALTH & social status, LUMBAR pain
Abstract

The authors discuss the improvement in health literacy in relation to ethnic minority musculoskeletal health. Topics mentioned include differences between the immigrant and indigenous populations with regard to back pain, knee pain, and widespread pain, the influence of health beliefs on ethnic minority health, and a need for culturally-competent health-care provision by health-care professionals trained in cultural competence.

Published
2018
Full Text
View/download PDF

41. Concurrent oral 2 - BHPR audit/service delivery and research.

Author

Robinson, Sandra and Walker, David

Subjects
*COGNITIVE therapy, *EXERCISE, *PATIENT compliance, *RHEUMATOID arthritis, *SEVERITY of illness index, *PSYCHOLOGY
Abstract

Background: The new NICE guidance on the management of RA suggests that a target for treatment is negotiated with patients. This seems to be a fusion between the “treat to target” studies that have suggested that multiple treatments are effective and the stated aim of putting the patient at the centre of their treatment. The details of how this should be done are not specified. We have previously found that patients have little understanding of the DAS score and that symptoms are too subjective to be used in this context. Restriction of a desired activity was suggested from the previous interviews. We were interested to explore this by negotiating targets with patients to see if it was possible in a clinic situation and what patients would specify as targets.Methods: 50 consecutive patients with RA were seen in selected clinics, and were asked to specify a target that could be used to assess how satisfactory their response to treatment was. They were asked if they understood what the DAS was and about their employment status and any impact of their arthritis on paid work.Results: None of the patients understood the DAS and only one had heard of it. All but 2 patients were able to express a target in terms of restricted activity. The negotiation added a total of 1 minute to the average consultation.48 expressed a target as either “maintaining” or “regaining” an activity. Six patients who were unhappy with their condition and wished to regain an activity, had their treatment increased. The remaining patients were content with their condition and did not want a change in therapy.The targets expressed by the 42 patients wishing to “maintain” their condition were: A distance they could walk 26 (62%); a leisure activity 6 (14%); a domestic activity 5(12%); remaining at work 4(10%) and personal care for 1 (2%).For the 6 wishing to “regain activities the targets were: A distance they could walk 2 (33%); a leisure activity 1 (17%) and a domestic activity 3(50%).Of 16 who were of working age, 5 were employed. 4 said that maintaining function to work was their target. 1 identified leisure activities. None of the patients who had lost their jobs because of arthritis expressed getting back to work as a target.Conclusions: Generally patients do not understand the DAS score and if they are to be used as targets there will need to be huge educational effort and may not be suitable for some patients. Patients are able to specify activities that are personal to them and could be used as targets to indicate whether change of treatment is necessary or has been successful. Patients who are happy with their condition express it as maintaining something whereas those unhappy express it as regain. How realistic and sensitive these targets are will take a follow-up study.Work is a target for those in work, but once the work has been lost it soon ceases to be a target. This suggests that maintaining people in work is likely to be more successful than trying to get them back to work later.Disclosure statement: The authors have declared no conflicts of interest. [ABSTRACT FROM PUBLISHER]

Published
2011
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results